10th Annual Symposium on Global Cancer Research (Pearline Award)

Rachel Pearline Award

OPENS: October 25, 2021 09:00AM U.S. Eastern Daylight Time
CLOSES: November 28, 2021 at 11:59pm Eastern Standard Time

Notification will be sent late January 2022

Submit a nomination for the 2022 Rachel Pearline Award here.

About the Rachel Pearline Award

The Rachel Pearline Award honors Rachel Pearline, MD, MPH. Dr. Pearline was a revered oncology fellow who received the award named in her memory in 2016 following her death at the age of 38, in November 2015, from gastric cancer. While in medical school, she completed rotations in South Africa, Haiti, Romania, and rural China where she learned to speak Mandarin fluently. For her work, she received a prestigious Fogarty International Clinical Research Fellowship and Tulane University’s award for “Outstanding International Relationships.” Dr. Pearline was virtuously committed to global cancer control and provided quality care to her patients. She viewed the practice of medicine as a privilege, always striving to serve her patients better.

The inaugural Rachel Pearline Award presentation in 2016 can be viewed here.

In honor of Dr. Rachel Pearline, the 10th Annual Symposium on Global Cancer Research Steering Committee would like to invite nominations for the Rachel Pearline Award. As part of the Symposium each year, we recognize one outstanding professional who embodies virtue and eminence in cancer research, practice, and/or training in a low- and middle-income country (LMIC) setting. The Steering Committee invites nominations of individuals, at any stage in their career, who have made major contributions to global cancer research, practice, and training. The nominee should be affiliated with an institution from a LMIC and their work should focus on cancer research, practice, and/or training in an LMIC setting.


The nominee will be recognized at the virtual Annual Symposium on Global Cancer Research on March 24, 2022. The nominee will be expected to take part in the award presentation ceremony as well as to give a keynote address that highlights their contributions to cancer research, practice, and/or training in an LMIC setting, and their future perspectives.

The Steering Committee will review nominations based on the following criteria:
1. Demonstration of commitment to and excellence in cancer research, practice, and/or training in an LMIC setting
2. Focus on reducing cancer care inequities through cancer research, practice, and/or training in an LMIC setting
3. Cancer control research, practice, and training activities either entirely or predominantly implemented in LMICs
4. Career stage and potential to contribute to cancer control in LMICs in the future

Additional eligibility criteria:

  1. Nominations submitted in previous years are accepted
  2. Self-nominations are accepted
  3. Nominee must confirm willingness/ability to accept the award and deliver a keynote address, virtually, at the Symposium in advance of nomination submission (confirmation to be stated within the nomination form).


Important Dates:
October 25, 2021, 09:00AM U.S. Eastern Daylight Time – Online nomination form opens.
November 28, 2021, 11:59PM U.S. Eastern Standard Time – Online abstract submission deadline.
January 2022– Notification of nomination winner.

For questions regarding the Rachel Pearline Award, please contact Taylor Estes, taylor.estes@nih.gov.


Previous Rachel Pearline Award Winners:

2021 Karla Alfaro, MD, MPH, Medical Director, Basic Health International, San Salvador, El Salvador 

2020 Frederick Chite Asirwa, MD, Consultant Physician, Medical Oncologist & Hematologist, CEO, International Cancer Institute (ICI), Eldoret, Kenya

2018 You-lin Qiao, MD, PhD, professor and Director for Department of Cancer Epidemiology, Cancer Institute, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, China.

2017 Carlos Rodriguez-Galindo, MD, Executive Vice President and Chair of the Department of Global Pediatric Medicine and Director of the International Outreach Program

2016 Rachel Pearline, MD, MPH, Diplomate of Medical Oncology